Targeting cancer's weaknesses (not its strengths): Therapeutic strategies suggested by the atavistic model.

Abstract excerpt

In the atavistic model of cancer progression, tumor cell dedifferentiation is interpreted as a reversion to phylogenetically earlier capabilities. The more recently evolved capabilities are compromised first during cancer progression. This suggests a therapeutic strategy for targeting cancer: design challenges to cancer that can only be met by the recently evolved capabilities no longer functional in cancer...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Proliferation
• Share to Energy Metabolism